These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 2957374)
41. A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. White MF; Shoelson SE; Keutmann H; Kahn CR J Biol Chem; 1988 Feb; 263(6):2969-80. PubMed ID: 2449432 [TBL] [Abstract][Full Text] [Related]
43. Insulin receptor desensitization correlates with attenuation of tyrosine kinase activity, but not of receptor endocytosis. Blake AD; Hayes NS; Slater EE; Strader CD Biochem J; 1987 Jul; 245(2):357-64. PubMed ID: 3311033 [TBL] [Abstract][Full Text] [Related]
44. Assessment of the in situ tyrosine kinase activity of mutant insulin receptors lacking tyrosine autophosphorylation sites 1162 and 1163. Yonezawa K; Roth RA Mol Endocrinol; 1991 Feb; 5(2):194-200. PubMed ID: 1710030 [TBL] [Abstract][Full Text] [Related]
45. Acute insulin action requires insulin receptor kinase activity: introduction of an inhibitory monoclonal antibody into mammalian cells blocks the rapid effects of insulin. Morgan DO; Roth RA Proc Natl Acad Sci U S A; 1987 Jan; 84(1):41-5. PubMed ID: 3540958 [TBL] [Abstract][Full Text] [Related]
46. Insulin stimulates sequestration of beta-adrenergic receptors and enhanced association of beta-adrenergic receptors with Grb2 via tyrosine 350. Karoor V; Wang L; Wang HY; Malbon CC J Biol Chem; 1998 Dec; 273(49):33035-41. PubMed ID: 9830057 [TBL] [Abstract][Full Text] [Related]
47. Insulin internalization in the absence of the insulin receptor tyrosine kinase domain is insufficient for mediating intracellular biological effects. Schranz DB; Rohilla AM; Anderson C; Wood WM; Berhanu P Biochem Biophys Res Commun; 1996 Oct; 227(2):600-7. PubMed ID: 8878559 [TBL] [Abstract][Full Text] [Related]
48. Relationship of site-specific beta subunit tyrosine autophosphorylation to insulin activation of the insulin receptor (tyrosine) protein kinase activity. Tornqvist HE; Avruch J J Biol Chem; 1988 Apr; 263(10):4593-601. PubMed ID: 2832399 [TBL] [Abstract][Full Text] [Related]
49. Functional properties of a naturally occurring Trp1200----Ser1200 mutation of the insulin receptor. Moller DE; Yokota A; Ginsberg-Fellner F; Flier JS Mol Endocrinol; 1990 Aug; 4(8):1183-91. PubMed ID: 1963473 [TBL] [Abstract][Full Text] [Related]
50. Interaction of the human insulin receptor tyrosine kinase from the baculovirus expression system with protein kinase C in a cell-free system. Ahn J; Donner DB; Rosen OM J Biol Chem; 1993 Apr; 268(10):7571-6. PubMed ID: 8463287 [TBL] [Abstract][Full Text] [Related]
51. Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. Takayama S; White MF; Kahn CR J Biol Chem; 1988 Mar; 263(7):3440-7. PubMed ID: 3125181 [TBL] [Abstract][Full Text] [Related]
52. Characterization of an insulin receptor mutant lacking the subunit processing site. Williams JF; McClain DA; Dull TJ; Ullrich A; Olefsky JM J Biol Chem; 1990 May; 265(15):8463-9. PubMed ID: 2187866 [TBL] [Abstract][Full Text] [Related]
53. Internalization and degradation of insulin by a human insulin receptor-v-ros hybrid in Chinese hamster ovary cells. Hari J; Yokono K; Yonezawa K; Roth RA; Baba S Biochem Biophys Res Commun; 1989 Feb; 158(3):705-11. PubMed ID: 2645866 [TBL] [Abstract][Full Text] [Related]
54. Mutation of a conserved amino acid residue (tryptophan 1173) in the tyrosine kinase domain of the IGF-I receptor abolishes autophosphorylation but does not eliminate biologic function. Blakesley VA; Kato H; Roberts CT; LeRoith D J Biol Chem; 1995 Feb; 270(6):2764-9. PubMed ID: 7852347 [TBL] [Abstract][Full Text] [Related]
56. Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor. Giorgetti S; Pelicci PG; Pelicci G; Van Obberghen E Eur J Biochem; 1994 Jul; 223(1):195-202. PubMed ID: 8033892 [TBL] [Abstract][Full Text] [Related]
57. Antibodies to the extracellular receptor domain restore the hormone-insensitive kinase and conformation of the mutant insulin receptor valine 382. Lebrun C; Baron V; Kaliman P; Gautier N; Dolais-Kitabgi J; Taylor S; Accili D; Van Obberghen E J Biol Chem; 1993 May; 268(15):11272-7. PubMed ID: 8388389 [TBL] [Abstract][Full Text] [Related]
58. Specificity of tyrosine protein kinases of the structurally related receptors for insulin and insulin-like growth factor I: Tyr-containing synthetic polymers as specific inhibitors or substrates. Sahal D; Ramachandran J; Fujita-Yamaguchi Y Arch Biochem Biophys; 1988 Jan; 260(1):416-26. PubMed ID: 2893587 [TBL] [Abstract][Full Text] [Related]
59. Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor. Elbaz N; Bedecs K; Masson M; Sutren M; Strosberg AD; Nahmias C Mol Endocrinol; 2000 Jun; 14(6):795-804. PubMed ID: 10847582 [TBL] [Abstract][Full Text] [Related]
60. Identification of serines-967/968 in the juxtamembrane region of the insulin receptor as insulin-stimulated phosphorylation sites. Liu F; Roth RA Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):471-7. PubMed ID: 8135757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]